CVC Credit Partners European Direct Lending Feeder Fund V has taken a significant step by filing a new offering with the SEC. This move is aimed at raising capital through a pooled investment fund, which is a notable development in the investment landscape.
The filing, dated November 12, 2026, indicates that the fund is structured as a limited partnership and is based in Luxembourg. This filing is particularly important as it highlights CVC's strategy to attract accredited investors while adhering to SEC regulations.
Background
CVC Credit Partners European Direct Lending Feeder Fund V (GBP) SCSp is categorized as a pooled investment fund, specifically an other investment fund. The fund is incorporated in Luxembourg and operates under the SEC's 1933 Act. Its recent filing on November 12, 2026, under Form D, reflects its ongoing efforts to establish a foothold in the investment market.
What the Filing Says
The SEC filing states that the offering is made under Rule 506(b), which provides a safe harbor for private offerings. The fund has indicated that it is not currently disclosing its aggregate net asset value, and the total offering amount is described as indefinite. The filing also mentions that the fund has yet to occur its first sale.
Impact
This development may affect various stakeholders, including potential investors looking for opportunities in private investment funds. The filing indicates that the fund does not plan to accept non-accredited investors, which aligns with its strategy to target a specific investor demographic. As CVC Credit Partners moves forward, it may influence other firms within the pooled investment sector to adjust their strategies.
What's Next
The filing does not specify what happens next. However, it is clear that CVC Credit Partners is positioning itself to engage with accredited investors in the near future.
Read Next
Dominion Energy announces $1.2 billion senior notes issuance
Lakefront Biotherapeutics Launches €50 Million Share Buyback
Coca-Cola Europacific Partners Announces Share Buyback Details
Zenta Group announces $6.47 million at-the-market offering
MapLight Therapeutics Enters $100 Million Sales Agreement
Cyabra, Inc. Secures $15.6 Million in Private Placement










